Cargando…
Survival After Transplantation in Patients With Mutations Other Than Val30Met: Extracts From the FAP World Transplant Registry
BACKGROUND: Liver transplantation (LTx) has been performed for hereditary transthyretin amyloidosis (ATTR) since 1990. Outcomes for a relatively large series of LTx ATTR patients with the Val30Met (mutation are available, but for non-Val30Met patients, only a few reports with a small number of patie...
Autores principales: | Suhr, Ole B., Larsson, Marie, Ericzon, Bo-Göran, Wilczek, Henryk E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4732012/ https://www.ncbi.nlm.nih.gov/pubmed/26656838 http://dx.doi.org/10.1097/TP.0000000000001021 |
Ejemplares similares
-
Neurophysiological pitfalls in TTR-FAP Val30Met
por: Conceição, Isabel, et al.
Publicado: (2015) -
Neurophysiological pitfalls in TTR-FAP Val30Met
por: Conceição, Isabel, et al.
Publicado: (2015) -
Atrial Fibrillation and Central Nervous Complications in Liver Transplanted Hereditary Transthyretin Amyloidosis Patients
por: Wange, Niklas, et al.
Publicado: (2018) -
Long-term Outcome of Endoscopic and Percutaneous Transhepatic Approaches for Biliary Complications in Liver Transplant Recipients
por: Rönning, Jesper, et al.
Publicado: (2019) -
Specific ocular changes in TTR Met30-FAP after liver transplantation
por: Ferreira, Natalia, et al.
Publicado: (2015)